-
DGDA temporarily bans Ranitidine in Bangladesh
-
After GSK, Sanofi decides on wind-up
-
Aggressive drug-resistant malaria spreading in south-east Asia
-
FDA approves new treatment for complicated urinary tract and complicated intra-abdominal i...
-
FDA approves first treatment for chronic rhinosinusitis with nasal polyps
-
Linagliptin Safe in Diabetes Across Age, Renal Groups
-
New JAK Inhibitor Hits Rheumatoid Arthritis Targets
-
Statins may double the risk of type 2 diabetes
-
EMA facilitates early engagement with medicine developers to combat antimicrobial resistan...
-
Study of Vitamin D Deficiency among the Apparently Healthy Population in Jashore, Banglade...
-
FDA Approves First Vaccine for Dengue, With Restrictions
-
Excess Vitamin D Linked to Kidney Damage
-
Alcohol abuse kills 3 million a year, most of them men: WHO
-
FDA approves device for treatment of acute coronary artery perforations
-
The FDA Just Approved Two HIV Drugs: Will This Change Treatment?
-
Scientists identify a new kind of human brain cell
-
Blood pressure and cholesterol lowering drugs continue to improve survival after a decade
-
Pharmaceutical companies are backing away from a growing threat that could kill 10 million...
-
Combining antibiotics changes their effectiveness
-
Creating medicines without side effects
-
FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients
-
Expats prefer Bangladeshi dentists for treatment
-
Health protection law on the cards
-
Improper diet, medical illiteracy fuels sale of pharmaceutical products